Profile of:

Jinxian Huang


Full name: Jinxian Huang

Current country: China

Membership level: Associate

Type of membership: Member

Number of publications: 7

Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial (2020)
https://pubmed.ncbi.nlm.nih.gov/33195311/

Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al (2020)
https://pubmed.ncbi.nlm.nih.gov/32933918/

Ixekizumab for the treatment of ankylosing spondylitis (2020)
https://pubmed.ncbi.nlm.nih.gov/32729361/

Placebo responses in ankylosing spondylitis patients worldwide: variations and possible explanations (2020)
https://pubmed.ncbi.nlm.nih.gov/32213079/

Synchronous Acute Acalculous Cholecystitis and Appendicitis Due to Salmonella Group D: A Rare Case Report From China and Review of the Literature (2020)
https://pubmed.ncbi.nlm.nih.gov/33015080/

Intensity of spinal inflammation is associated with radiological structural damage in patients with active axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/32016167/

Altered expression of microRNAs targeting Dkk-1 in peripheral blood mononuclear cells of patients with ankylosing spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/31114438/